HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Overview of attention for article published in Nature Medicine, March 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent: 11 patents
wikipedia: 1 Wikipedia page

guideline: 1 clinical guideline source

Readers on

mendeley: 329 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

So far, Altmetric has seen 11 patents that reference this research output.

Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen…

Grant US-11666651-B2

United States of America

06 Jun 2023

DOSAGE REGIMENS FOR VACCINES

Application WO-2021094984-A1

World Intellectual Property Organisation (WIPO)

20 May 2021

DOSAGE REGIMENS FOR VACCINES

Application WO-2020234839-A1

World Intellectual Property Organisation (WIPO)

26 Nov 2020

Compositions and methods related to characterizing proviral reservoirs

Grant US-10806748-B2

United States of America

20 Oct 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 7 additional patents.